Rankings
▼
Calendar
INGN Q4 2025 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena
INGN
Inogen, Inc.
$171M
Q4 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$82M
+2.0% YoY
Gross Profit
$41M
50.4% margin
Operating Income
-$9M
-11.4% margin
Net Income
-$7M
-8.7% margin
EPS (Diluted)
$-0.26
QoQ Revenue Growth
-11.5%
Cash Flow
Operating Cash Flow
-$943,000
Free Cash Flow
-$3M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$299M
Total Liabilities
$106M
Stockholders' Equity
$192M
Cash & Equivalents
$104M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$82M
$80M
+2.0%
Gross Profit
$41M
$36M
+13.6%
Operating Income
-$9M
-$11M
+18.3%
Net Income
-$7M
-$10M
+27.0%
Geographic Segments
UNITED STATES
$49M
60%
Non-US
$33M
40%
← FY 2025
All Quarters